- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01319747
Video-Assisted Thoracoscopic Pulmonary Vein Isolation Versus Percutaneous Catheter Ablation in Atrial Fibrillation Trial (VATCAT)
Recent studies demonstrated that radiofrequency isolation of the pulmonary veins (PVI) and surgically video assisted thorascopic pulmonary vein isolation (VATS-PVI) are acceptable or even superior alternatives to antiarrhythmic drug therapy in patients with symptomatically paroxysmal atrial fibrillation (AF). However, data comparing effectiveness in both interventions are limited.
The investigators want to compare the effectiveness of PVI and VATS-PVI. Secondary objectives are to compare the duration of hospitalization, quality of Life, cost and to compare the satisfaction of the patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
OV
-
Enschede, OV, Netherlands, 7500KA
- Medisch Spectrum Twente
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients > 18 years of age
- Documented, symptomatic, episodes of paroxysmal or persistent AF
- During the last 6 months patients must have at least 2 documented episodes of AF, despite the use of at least 1 anti arrhythmic drug.
- Able of providing informed consent
Exclusion Criteria:
- Pregnancy
- Unwillingness to use or contra-indications for vitamin K antagonists
- Severely enlarged left atrium (>50 mm) on echocardiography
- Prior AF ablation or AF surgery
- Intracardiac thrombus
- Prior heart surgery or pulmonary disease hampering thoracoscopic surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Percutaneous therapy
|
For catheter ablation, we used irrigated 4mm RF-ablation catheters, at a maximum power of 30-35Watt, an irrigation rate of 20 mL/min.
PV isolation was performed by wide circumferential ablation, encircling all ipsilateral PVs.
|
Active Comparator: VATS therapy
|
A bilateral video-assisted thoracoscopic (VATS) pulmonary vein isolation and left atrial appendage (LAA) excision is performed under general anaesthesia and double-lumen endotracheal ventilation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence of AF
Time Frame: one year
|
The percentage of patients without a recurrence of AF, without antiarrhythmic drugs (AADs), within a follow-up period of at least 12 months after a stabilisation period of 90 days after the initial procedure.
An episode of AF is defined as an episode of at least 30 seconds duration.
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Treatment impact
Time Frame: one year
|
Secondary objectives include the duration and cost of hospitalization, discomfort during admission, assessment and experienced AF burden during follow-up of procedural impact on the patient and time to recurrence after intervention.
A complication register will also be kept.
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcoen Scholten, MD PhD, Medisch Spectrum Twente
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL32865.044.10
- 32865 (Other Identifier: CCMO ABR Nummer)
- Dutch trial register entry (Registry Identifier: NTR2455)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
Beijing Anzhen HospitalJohnson & Johnson; Heart Health Research CenterNot yet recruitingParoxysmal Atrial Fibrillation | Persistent Atrial Fibrillation
-
Maastricht UniversityRadboud University Medical Center; Maastricht University Medical CenterRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Atrial Fibrillation ParoxysmalNetherlands
Clinical Trials on PVI
-
Abbott Medical DevicesCompletedAtrial FibrillationCanada, Australia
-
AtriCure, Inc.Completed
-
Meshalkin Research Institute of Pathology of CirculationUnknownAtrial Fibrillation | Arterial HypertensionRussian Federation, United States
-
The Second Affiliated Hospital of Kunming Medical...Completed
-
Volta MedicalCovance; CardiaBaseActive, not recruitingAtrial FibrillationUnited States, Germany, Belgium, France, Netherlands
-
The Second Affiliated Hospital of Kunming Medical...First Affiliated Hospital of Kunming Medical UniversityRecruitingAtrial FibrillationChina
-
Osaka Cardiovascular ConferenceUnknownRecurrence | Atrial Fibrillation | Catheter Ablation
-
AZ Sint-Jan AVActive, not recruiting
-
University Hospital, BordeauxFunding: European Commission (H2020)Active, not recruitingAtrial FibrillationFrance, Czechia, Austria, Germany, Belgium
-
Universitätsklinikum Hamburg-EppendorfAbbott Medical DevicesCompletedAtrial Fibrillation | Persistent Atrial FibrillationGermany